HEMBLIVIX Trademark

Trademark Overview

On Thursday, February 25, 2016, a trademark application was filed for HEMBLIVIX with the United States Patent and Trademark Office. The USPTO has given the HEMBLIVIX trademark a serial number of 79185619. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, April 21, 2023. This trademark is owned by Novo Nordisk Health Care AG. The HEMBLIVIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for hemostasis management
hemblivix

General Information

Serial Number79185619
Word MarkHEMBLIVIX
Filing DateThursday, February 25, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, April 21, 2023
Registration Number5052055
Registration DateTuesday, October 4, 2016
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 19, 2016

Trademark Statements

Goods and ServicesPharmaceutical preparations for hemostasis management

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 21, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk Health Care AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH
Party NameNovo Nordisk Health Care AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events

Event DateEvent Description
Monday, January 29, 2024TOTAL INVALIDATION PROCESSED BY THE IB
Saturday, January 6, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Saturday, January 6, 2024INVALIDATION PROCESSED
Thursday, December 21, 2023TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 21, 2023CANCELLED SECTION 71
Sunday, November 21, 2021NEW REPRESENTATIVE AT IB RECEIVED
Friday, August 6, 2021CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, December 2, 2016NOTIFICATION PROCESSED BY IB
Thursday, November 17, 2016FINAL DISPOSITION NOTICE SENT TO IB
Thursday, November 17, 2016FINAL DISPOSITION PROCESSED
Thursday, November 3, 2016GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, October 4, 2016REGISTERED-PRINCIPAL REGISTER
Friday, September 23, 2016NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, July 19, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 29, 2016NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, June 29, 2016NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, June 29, 2016NOTICE OF PUBLICATION
Monday, June 13, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, June 10, 2016ASSIGNED TO EXAMINER
Wednesday, April 13, 2016APPLICATION FILING RECEIPT MAILED
Tuesday, April 12, 2016APPLICATION FILING RECEIPT MAILED
Wednesday, April 6, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

hemblivix management hemostasis preparations pharmaceutical